{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:47:19Z","timestamp":1791121639887,"version":"4.1.0"},"reference-count":48,"publisher":"European Respiratory Society (ERS)","issue":"129","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2013,6,21]]},"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) is a rare disorder characterised by progressive obliteration of the pulmonary microvasculature resulting in elevated pulmonary vascular resistance and premature death. According to the current classification PAH can be associated with exposure to certain drugs or toxins, particularly to appetite suppressant intake drugs, such as aminorex, fenfluramine derivatives and benfluorex. These drugs have been confirmed to be risk factors for PAH and were withdrawn from the market. The supposed mechanism is an increase in serotonin levels, which was demonstrated to act as a growth factor for the pulmonary artery smooth muscle cells. Amphetamines, phentermine and mazindol were less frequently used, but are considered possible risk factors, for PAH. Dasatinib, dual Src\/Abl kinase inhibitor, used in the treatment of chronic myelogenous leukaemia was associated with cases of severe PAH, potentially in part reversible after dasatinib withdrawal. Recently, several studies have raised the issue of potential endothelial dysfunction that could be induced by interferon, and a few cases of PAH have been reported with interferon therapy. PAH remains a rare complication of these drugs, suggesting possible individual susceptibility, and further studies are needed to identify patients at risk of drug-induced PAH.<\/jats:p>","DOI":"10.1183\/09059180.00003313","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T21:29:40Z","timestamp":1377898180000},"page":"244-250","source":"Crossref","is-referenced-by-count":94,"title":["Drug-induced pulmonary arterial hypertension: a recent outbreak"],"prefix":"10.1183","volume":"22","author":[{"given":"David","family":"Montani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Seferian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Savale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Simonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"2025042406001644000_22.129.244.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199701093360207"},{"key":"2025042406001644000_22.129.244.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.012"},{"key":"2025042406001644000_22.129.244.3","first-page":"818","article-title":"Chronische pulmonale Hypertonie vaskularen Ursprungs, plexogene pulmonale Arteriopathie und der Appetitzugler Aminorex: Nachlese zu einer Epidemie [Chronic pulmonary hypertension of vascular aetiology, plexogenic pulmonary arteriopathy and the appetite depressant Aminorex: lessons from an epidemic]","volume":"115","author":"Gurtner","year":"1985","journal-title":"Schweiz Med Wochenschr"},{"key":"2025042406001644000_22.129.244.4","first-page":"160","article-title":"Aminorex and pulmonary hypertension: a review","volume":"27","author":"Gurtner","year":"1985","journal-title":"Cor Vasa"},{"key":"2025042406001644000_22.129.244.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00139009"},{"key":"2025042406001644000_22.129.244.6","doi-asserted-by":"publisher","DOI":"10.1136\/thx.26.3.262"},{"key":"2025042406001644000_22.129.244.7","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.3_Supplement.195S"},{"key":"2025042406001644000_22.129.244.8","doi-asserted-by":"publisher","DOI":"10.1186\/rr181"},{"key":"2025042406001644000_22.129.244.9","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2002.122181"},{"key":"2025042406001644000_22.129.244.10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.3_suppl.97S"},{"key":"2025042406001644000_22.129.244.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80156-9"},{"key":"2025042406001644000_22.129.244.12","first-page":"111","article-title":"Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake","volume":"27","author":"Loogen","year":"1985","journal-title":"Cor Vasa"},{"key":"2025042406001644000_22.129.244.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.283.6296.881"},{"key":"2025042406001644000_22.129.244.14","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.70.6.537"},{"key":"2025042406001644000_22.129.244.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608293350901"},{"key":"2025042406001644000_22.129.244.16","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00104807"},{"key":"2025042406001644000_22.129.244.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00086308"},{"key":"2025042406001644000_22.129.244.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010128"},{"key":"2025042406001644000_22.129.244.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00188611"},{"key":"2025042406001644000_22.129.244.20","first-page":"1283","article-title":"Pulmonale arteriele hypertensie door amfetaminen gebruikt als drugs of doping [Pulmonary arterial hypertension due to the use of amphetamines as drugs or doping]","volume":"149","author":"van Wolferen","year":"2005","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2025042406001644000_22.129.244.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(96)90160-2"},{"key":"2025042406001644000_22.129.244.22","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90459-X"},{"key":"2025042406001644000_22.129.244.23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.2.614"},{"key":"2025042406001644000_22.129.244.24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.6.1657"},{"key":"2025042406001644000_22.129.244.25","doi-asserted-by":"publisher","DOI":"10.1007\/s007020050121"},{"key":"2025042406001644000_22.129.244.26","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000126847.27660.69"},{"key":"2025042406001644000_22.129.244.27","doi-asserted-by":"publisher","DOI":"10.1378\/chest.115.6.1708"},{"key":"2025042406001644000_22.129.244.28","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0800920"},{"key":"2025042406001644000_22.129.244.29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.3.870"},{"key":"2025042406001644000_22.129.244.30","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.64.218"},{"key":"2025042406001644000_22.129.244.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2012.07.008"},{"key":"2025042406001644000_22.129.244.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441401"},{"key":"2025042406001644000_22.129.244.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0123OC"},{"key":"2025042406001644000_22.129.244.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.09.026"},{"key":"2025042406001644000_22.129.244.35","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.415"},{"key":"2025042406001644000_22.129.244.36","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00154210"},{"key":"2025042406001644000_22.129.244.37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.079921"},{"key":"2025042406001644000_22.129.244.38","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00091912"},{"key":"2025042406001644000_22.129.244.39","doi-asserted-by":"publisher","DOI":"10.1016\/0270-9139(95)90216-3"},{"key":"2025042406001644000_22.129.244.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212203"},{"key":"2025042406001644000_22.129.244.41","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90131-7"},{"key":"2025042406001644000_22.129.244.42","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10319"},{"key":"2025042406001644000_22.129.244.43","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1220-7"},{"key":"2025042406001644000_22.129.244.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(99)00107-7"},{"key":"2025042406001644000_22.129.244.45","doi-asserted-by":"publisher","DOI":"10.1186\/1476-7120-3-26"},{"key":"2025042406001644000_22.129.244.46","doi-asserted-by":"publisher","DOI":"10.1159\/000335064"},{"key":"2025042406001644000_22.129.244.47","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509104593"},{"key":"2025042406001644000_22.129.244.48","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00075211"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09059180.00003313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:00:26Z","timestamp":1745485226000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09059180.00003313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":48,"journal-issue":{"issue":"129","published-online":{"date-parts":[[2013,8,30]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1183\/09059180.00003313"],"URL":"https:\/\/doi.org\/10.1183\/09059180.00003313","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}